CE 1037

Drug Profile

CE 1037

Alternative Names: MDL 201404; UT 77

Latest Information Update: 30 Jun 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cortech; The Research Foundation of State University of New York
  • Class
  • Mechanism of Action Leucocyte elastase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Adult respiratory distress syndrome; Chronic obstructive pulmonary disease; Cystic fibrosis; Emphysema

Most Recent Events

  • 30 Jun 2000 Discontinued-II for Adult respiratory distress syndrome in USA (Unknown route)
  • 30 Jun 2000 Discontinued-II for Chronic obstructive pulmonary disease in USA (Unknown route)
  • 30 Jun 2000 Discontinued-II for Cystic fibrosis in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top